Australia's most trusted
source of pharma news
Monday, 16 February 2026
Posted 16 February 2026 AM
Glenmark has become the first company to register a generic of MSD’s PBS listed Stromectol under the brand name Glenmect.
The oral ivermectin-containing medicine is registered on the ARTG for the treatment of onchocerciasis and intestinal strongyloidiasis, crusted scabies in conjunction with topical therapy, and human sarcoptic scabies when prior topical treatment has failed or is contraindicated.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.